United Therapeutics And MannKind Announce Collaboration For Pulmonary Hypertension Products
Exclusive license agreement for Treprostinil Technosphere®; $95 million in upfront and milestone payments
Research agreement for additional products for additional $10 million
SILVER SPRING, Md. and WESTLAKE VILLAGE, Calif., Sept. 4, 2018 -- (Hea... Biopharmaceuticals, Licensing United Therapeutics, MannKind, Treprostinil, Technosphere
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Hypertension | Pulmonary Hypertension